MIRA Pharmaceuticals, Inc.
MIRA
$0.96
-$0.01-1.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.44M | -6.86M | -7.77M | -7.92M | -7.85M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.35M | 2.13M | 2.18M | 2.30M | 1.92M |
| Change in Net Operating Assets | -567.60K | -598.80K | -492.00K | -517.90K | 371.20K |
| Cash from Operations | -4.66M | -5.33M | -6.08M | -6.14M | -5.56M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 572.90K | 0.00 | 348.70K | -- | -- |
| Total Debt Repaid | -- | 14.50K | 0.00 | 24.30K | 0.00 |
| Issuance of Common Stock | 7.90M | 3.95M | 3.61M | 3.61M | 3.61M |
| Repurchase of Common Stock | -3.40K | -3.40K | -3.40K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -292.50K | -134.10K | 26.20K | 182.40K | 182.40K |
| Cash from Financing | 8.18M | 3.83M | 3.98M | 3.82M | 3.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.51M | -1.50M | -2.09M | -2.32M | -1.77M |